India’s Cipla gets tentative FDA nod for topiramate
June 1st, 2008 | by admin |MUMBAI, June 1 (Reuters) - Indian drugmaker Cipla Ltd(CIPL.BO: Quote, Profile, Research) has received tentative approval from the U.S. Foodand Drug Administration for generic epilepsy drug topiramatetablets, the regulator’s website showed. (Reporting by Rina Chandran; Editing by Kim Coghill)
